Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Price to Book Ratio 2021–2026
Price to book (P/B) ratio for Lyell Immunopharma, Inc. (LYEL): market cap divided by shareholder equity. As of March 31, 2026 it is 1.77.
From: 06/30/2021To: 03/31/2026
Stock Price
Book Value
Price to Book
Lyell Immunopharma, Inc. Price to Book Ratio — FAQ
Lyell Immunopharma, Inc. (LYEL) price to book ratio over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's price to book ratio history?
The chart and table above show Lyell Immunopharma, Inc.'s price to book ratio by year and by quarter, including the growth rate.